Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.
复制标题
DOI:
10.1021/acscentsci.1c00070
复制
发表时间:
2021-05-26
影响因子:
18.2
通讯作者:
Bernardes GJL
中科院分区:
文献类型:
--
作者:
Conde J;Pumroy RA;Baker C;Rodrigues T;Guerreiro A;Sousa BB;Marques MC;de Almeida BP;Lee S;Leites EP;Picard D;Samanta A;Vaz SH;Sieglitz F;Langini M;Remke M;Roque R;Weiss T;Weller M;Liu Y;Han S;Corzana F;Morais VA;Faria CC;Carvalho T;Filippakopoulos P;Snijder B;Barbosa-Morais NL;Moiseenkova-Bell VY;Bernardes GJL
The use of computational tools to identify biological targets of natural products with anticancer properties and unknown modes of action is gaining momentum. We employed self-organizing maps to deconvolute the phenotypic effects of piperlongumine (PL) and establish a link to modulation of the human transient receptor potential vanilloid 2 (hTRPV2) channel. The structure of the PL-bound full-length rat TRPV2 channel was determined by cryo-EM. PL binds to a transient allosteric pocket responsible for a new mode of anticancer activity against glioblastoma (GBM) in which hTRPV2 is overexpressed. Calcium imaging experiments revealed the importance of Arg539 and Thr522 residues on the antagonistic effect of PL and calcium influx modulation of the TRPV2 channel. Downregulation of hTRPV2 reduces sensitivity to PL and decreases ROS production. Analysis of GBM patient samples associates hTRPV2 overexpression with tumor grade, disease progression, and poor prognosis. Extensive tumor abrogation and long term survival was achieved in two murine models of orthotopic GBM by formulating PL in an implantable scaffold/hydrogel for sustained local therapy. Furthermore, in primary tumor samples derived from GBM patients, we observed a selective reduction of malignant cells in response to PL ex vivo. Our results establish a broadly applicable strategy, leveraging data-motivated research hypotheses for the discovery of novel means tackling cancer. We computationally identify and experimentally validate TRPV2 as a target for piperlongumine and establish a link between allosteric target engagement and impaired glioblastoma progression in vivo.
登录
查看更多内容
DOI:
10.1002/anie.201411511
发表时间:
2015-03-16
期刊:
Angewandte Chemie (International ed. in English)
影响因子:
--
作者:
Akbulut Y;Gaunt HJ;Muraki K;Ludlow MJ;Amer MS;Bruns A;Vasudev NS;Radtke L;Willot M;Hahn S;Seitz T;Ziegler S;Christmann M;Beech DJ;Waldmann H
通讯作者:
Waldmann H
影响因子:
41.2
作者:
Conde J;Oliva N;Atilano M;Song HS;Artzi N
通讯作者:
Artzi N
影响因子:
4.7
作者:
Jacobs VL;Valdes PA;Hickey WF;De Leo JA
通讯作者:
De Leo JA
DOI:
10.1016/j.bbrc.2013.06.042
发表时间:
2013-07-19
影响因子:
3.1
作者:
Liu, Ju Mei;Pan, Feng;Chen, Xiao Qian
通讯作者:
Chen, Xiao Qian
影响因子:
3.5
作者:
Kapoor, Shobhna;Waldmann, Herbert;Ziegler, Slava
通讯作者:
Ziegler, Slava